Webma et al. bmc cancer (2024) 20:280 research article open access management and prognostic prediction of appendiceal mucinous adenocarcinoma with peritoneal WebDec 11, 2024 · The objective of this study is to prove that treatment with primary cytoreductive surgery in combination with HIPEC (treatment arm) improves outcome compared to primary cytoreductive surgery without HIPEC (standard arm) with acceptable morbidity, in patients with FIGO stage III epithelial ovarian cancer who are eligible for …
Cytoreduction With or Without Intraoperative Intraperitoneal ...
WebJul 18, 2024 · Cytoreductive surgery and hyperthermic (heated) intraperitoneal chemotherapy (HIPEC) are two separate procedures that are usually performed … WebDec 31, 2014 · Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma (CARCINOHIPEC) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. binghamton public works
Primary cytoreductive surgery with or without hyperthermic ...
WebIn this study, published in the Journal of Clinical Oncology (JCO) in 2024, patients were randomly assigned to either secondary cytoreductive surgery (CRS) with HIPEC followed by five cycles of carboplatinum-based chemotherapy or CRS followed by six cycles of carboplatinum-based chemotherapy. WebThe reiteration of surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients affected by recurrent peritoneal metastases is still … WebJan 28, 2024 · Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteristics and clinical course of long-term survivors with CRC-PM beyond 5 years. binghamton real estate